Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.
Atas U, Salim O, Iltar U, Yucel OK, Kucukdiler Eroglu AH, Aslan V, Yildirim M, Dedeoglu O, Secilmis S, Ulas T, Deveci B, Karaman Gulsaran S, Geduk A, Yaman F, Pinar IE, Maral S, Sarici A, Celik S, Ogul H, Gulkan Ozkan S, Gemici A, Gunes AK, Tombak A, Yavasoglu I, Karakus V, Comert M, Toptas T, Dal MS, Saba R, Kirgizlar HO, Mehtap O, Gunduz E, Ozkalemkas F, Albayrak M, Berber I, Keklik M, Guler N, Ozkan HA, Sevindik OG, Bolaman Z, Kurtoglu E, Ayli M, Firatli Tuglular T, Altuntas F, Undar L. Atas U, et al. Among authors: sevindik og. Turk J Haematol. 2024 Nov 6. doi: 10.4274/tjh.galenos.2024.2024.0450. Online ahead of print. Turk J Haematol. 2024. PMID: 39501735 Free article.
Germline CEBPA Mutation as a Rare Cause of Chronic Neutropenia.
Askin AE, Bektas S, Serin I, Mutlu YG, Aydin BB, Sevindik OG. Askin AE, et al. Among authors: sevindik og. Indian J Hematol Blood Transfus. 2024 Jul;40(3):527-530. doi: 10.1007/s12288-023-01725-3. Epub 2024 Jan 6. Indian J Hematol Blood Transfus. 2024. PMID: 39011240 No abstract available.
Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience.
Yiğit Kaya S, Mutlu YG, Malkan ÜY, Mehtap Ö, Keklik Karadağ F, Korkmaz G, Elverdi T, Saydam G, Özet G, Ar MC, Melek E, Maral S, Kaynar L, Sevindik ÖG. Yiğit Kaya S, et al. Among authors: sevindik og. Leuk Res. 2024 May;140:107495. doi: 10.1016/j.leukres.2024.107495. Epub 2024 Mar 29. Leuk Res. 2024. PMID: 38599153
Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience.
Kilic Gunes E, Yigit Kaya S, Yaman F, Yeniay MK, Vural K, Comert M, Sevindik OG, Andic N, Dagdas S, Nizam Ozen I, Kaynar L, Yavasoglu F, Ozet G, Karakus V, Ayli M. Kilic Gunes E, et al. Among authors: sevindik og. Leuk Res. 2024 May;140:107484. doi: 10.1016/j.leukres.2024.107484. Epub 2024 Mar 15. Leuk Res. 2024. PMID: 38520796
[Intravaskuläres B-Zell-Lymphom mit generalisierten Teleangiektasien].
Erol VB, Mutlu YG, Balik B, Mert A, Mergen S, Mergen M, Serin I, Cakir A, Ozden F, Sevindik OG. Erol VB, et al. Among authors: sevindik og. J Dtsch Dermatol Ges. 2023 Sep;21(9):1025-1028. doi: 10.1111/ddg.15148_g. J Dtsch Dermatol Ges. 2023. PMID: 37700402 German. No abstract available.
45 results